Results 171 to 180 of about 117,359 (326)
3501 MRP Based Inventory Management for Supply Chain Model
, 2008 Tatsuhiko SAKAGUCHI +3 more
openalex +1 more source
Drug Product Development of Lipid Nanoparticle‐Based mRNA Therapeutics and Vaccines
WIREs Nanomedicine and Nanobiotechnology, Volume 18, Issue 2, March/April 2026.Overview of the development path from an mRNA–lipid nanoparticle (LNP) concept to a licensed drug product, covering LNP design, manufacturing process development, formulation, and analytical characterization. ABSTRACT Lipid nanoparticles (LNP) are currently the most relevant non‐viral delivery systems for mRNA and occasionally for smaller nucleic acids
Gideon Kersten +4 more
wiley +1 more source
Effective production control in an automotive industry: MRP vs. demand-driven MRP
, 2017 M. J. Shofa, W. O. Widyarto
semanticscholar +1 more source
Active Yeast Telomerase Shares Subunits with Ribonucleoproteins RNase P and RNase MRP.
Cell, 2016 B. Lemieux +6 more
semanticscholar +1 more source
Birth, Volume 53, Issue 1, Page 120-128, March 2026.ABSTRACT Introduction Nearly half of all perinatal deaths occur during the intrapartum period due to inadequate labor monitoring and intervention. The partograph, a paper‐based labor monitoring tool, can assist providers in recognizing and acting on early signs of fetal–maternal distress if used effectively. In 2020, the World Health Organization (WHO)
Elizabeth Armari +24 more
wiley +1 more source
Clinical Genetics, Volume 109, Issue 3, Page 581-585, March 2026.We hereby report the first prenatal diagnosis of MSL2‐related pathology, namely ventriculomegaly. Favorable 11‐month follow‐up illustrates the challenges in predicting postnatal outcomes for genetic anomalies linked to recently characterized phenotypes with limited documented cases.
Omar Zgheib +12 more
wiley +1 more source
Comparison of Human and Canine P‐Glycoprotein Substrates at R, P, and H Binding Sites
Journal of Veterinary Pharmacology and Therapeutics, Volume 49, Issue 2, Page 120-130, March 2026.ABSTRACT P‐glycoprotein (P‐gp) greatly impacts substrate drug disposition, so much so that regulatory agencies recommend ascertaining the P‐gp status of active pharmaceutical ingredients (APIs) intended for human use. Arguably, the P‐gp status of drugs intended for canine patients is equally, if not more, important.
Neal S. Burke, Katrina L. Mealey
wiley +1 more source